Tranche Update on InBody Co., Ltd.'s Equity Buyback Plan announced on December 21, 2018.
March 25, 2019 at 04:17 am
Share
From December 21, 2018 to December 31, 2018, the company has repurchased 22,317 shares, representing 0.17% for KRW 467.36 million. With this, the company has completed the repurchase of 22,317 shares, representing 0.17% for KRW 467.36 million under the buyback announced on December 21, 2018.
InBody Co., Ltd., formerly Biospace Co., Ltd., is a Korea-based company engaged in the manufacture of electronic medical devices. The Company mainly produces body composition analyzers under the brand names of InBody and LookinâBody. The Company mainly produces body composition analyzers under the brand name InBody and LookinâBody. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include LookinâBody3.0 and LookinâBody Basic, which are used for measuring proteins, minerals, fats, moistures and others. It also provides body mass index (BMI) measuring devices under the brand name of BSM. The Company distributes its products within domestic market and to overseas markets.
INBODY CO.,LTD 
